Effects of Structured Follow-Up and of More Effective Acid Inhibitory Treatment in the Management of GORD Patients in a Swedish Primary-Care Setting: A Randomized, Open-Label Study

Author： Ekesbo Rickard  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.31, Iss.3, 2011-03, pp. : 181-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of Low-Dose Atorvastatin and Rosuvastatin on Plasma Lipid Profiles: A Long-Term, Randomized, Open-Label Study in Patients with Primary Hypercholesterolemia

By Mazza Fabio   Stefanutti Claudia   Serafina Di Giacomo   Vivenzio Antonio   Fraone Nadia   Mazzarella Bruno   Bucci Antonello  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 4, 2008-01 ,pp. : 265-270

Adis International

Access to resources Recommend Favorite

Effects of Two Administration Schemes of Intramuscular Clodronic Acid on Bone Mineral Density: A Randomized, Open-Label, Parallel-Group Study

By Frediani Bruno  

Clinical Drug Investigation, Vol. 31, Iss. 1, 2011-01 ,pp. : 43-50

Adis International

Access to resources Recommend Favorite

Pleiotropic Effects of Sevelamer Beyond Phosphate Binding in End-Stage Renal Disease Patients: A Randomized, Open-Label, Parallel-Group Study

By Lin Yu-Feng   Chien Chiang-Ting  

Clinical Drug Investigation, Vol. 31, Iss. 4, 2011-04 ,pp. : 257-267

Adis International

Access to resources Recommend Favorite

Clinical and Economic Comparison of Sertraline and Fluoxetine in the Treatment of Depression: A 6-Month Double-Blind Study in a Primary-Care Setting in France

By Boyer P.  

PharmacoEconomics, Vol. 13, Iss. 1 Part 2, 1998-01 ,pp. : 157-169

Adis International

Access to resources Recommend Favorite

Long-Term Effects of Rivastigmine Treatment on the Need for Psychotropic Medications in Nursing Home Patients with Alzheimer’s Disease: Results of a 52-Week Open-Label Study

By Edwards Keith  

Clinical Drug Investigation, Vol. 25, Iss. 8, 2005-01 ,pp. : 507-515

Adis International

Access to resources Recommend Favorite